Pictet Asset Management (UK)’s Vanda Pharmaceuticals VNDA Stock Holding History

Pictet Asset Management (UK)’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	$5.33M	Sell	247,538 -72,395	-23%	-$1.3M	0.01%	835
2021 Q1	$4.8M	Sell	319,933 -43,300	-12%	-$701K	0.01%	843
2020 Q4	$4.77M	Sell	363,233 -26,200	-7%	-$315K	0.01%	828
2020 Q3	$3.76M	Sell	389,433 -90,751	-19%	-$970K	0.01%	790
2020 Q2	$5.49M	Sell	480,184 -95,068	-17%	-$1.08M	0.01%	658
2020 Q1	$5.96M	Buy	575,252 +127,000	+28%	+$1.57M	0.01%	597
2019 Q4	$7.36M	Sell	448,252 -71,648	-14%	-$1.08M	0.01%	665
2019 Q3	$6.9M	Buy	519,900 +43,900	+9%	+$612K	0.01%	625
2019 Q2	$6.71M	Buy	476,000 +104,200	+28%	+$1.66M	0.01%	621
2019 Q1	$6.84M	Buy	371,800 +121,900	+49%	+$2.78M	0.02%	626
2018 Q4	$6.53K	Buy	249,900 +68,100	+37%	+$1.6M	0.02%	597
2018 Q3	$4.17M	Sell	181,800 -24,900	-12%	-$508K	0.01%	777
2018 Q2	$3.94M	Buy	+206,700	New	+$3.46M	0.01%	711

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Pictet Asset Management (UK)'s VNDA Position: Q2 2021 in Review

Pictet Asset Management (UK) reduced its Vanda Pharmaceuticals (VNDA) stake by 23% in Q2 2021, selling an estimated $1.3M and leaving 247,538 shares worth $5.33M. The position accounts for 0.01% of the portfolio, ranked #835.

Pictet Asset Management (UK) first reported a position in VNDA in Q2 2018 and has held it in 13 quarters since. The position peaked at $7.36M in Q4 2019. 181 funds tracked by Wall St. Rank hold VNDA as of Q2 2021.

Pictet Asset Management (UK) held 247,538 shares of Vanda Pharmaceuticals worth $5.33M as of Q2 2021.
Pictet Asset Management (UK) sold 72,395 Vanda Pharmaceuticals shares in Q2 2021, an estimated $1.3M.
Vanda Pharmaceuticals made up 0.01% of Pictet Asset Management (UK)'s portfolio in Q2 2021, its #835 holding.
Pictet Asset Management (UK) first reported a position in Vanda Pharmaceuticals in Q2 2018 and has held it in 13 quarters since.
Pictet Asset Management (UK)'s Vanda Pharmaceuticals position peaked at $7.36M in Q4 2019.
181 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2021.

Based on Pictet Asset Management (UK)'s 13F filing for Q2 2021, filed 16 Aug 2021.